Mouse Models as a Tool for Understanding Progression in BrafV600E-Driven Thyroid Cancers
Iñigo Landa (Landa I), Jeffrey A. Knauf (Knauf JA)
Endocrinol Metab. 2019;34(1):11-22.   Published online 2019 Feb 15     DOI: https://doi.org/10.3803/EnM.2019.34.1.11
Citations to this article as recorded by Crossref logo
An Animal Model Further Uncovers the Role of Mutant Braf during Papillary Thyroid Cancer Development
Bernd Koelsch, Sarah Theurer, Magdalena Staniszewska, Jacqueline Heupel, Amelie Koch, Svenja Mergener, Franziska Walk, Christine Fischer, Andrea Kutritz, Kurt W. Schmid, Andrea Kindler-Röhrborn
The American Journal of Pathology.2020; 190(3): 702.     CrossRef
Intratumoral Genetic Heterogeneity in Papillary Thyroid Cancer: Occurrence and Clinical Significance
Laura Fugazzola, Marina Muzza, Gabriele Pogliaghi, Mario Vitale
Cancers.2020; 12(2): 383.     CrossRef
The Aryl Hydrocarbon Receptor Is Expressed in Thyroid Carcinoma and Appears to Mediate Epithelial-Mesenchymal-Transition
Sonia Moretti, Nicole Nucci, Elisa Menicali, Silvia Morelli, Vittorio Bini, Renato Colella, Martina Mandarano, Angelo Sidoni, Efisio Puxeddu
Cancers.2020; 12(1): 145.     CrossRef